Bio
Dr. Massarweh specializes in breast cancer, with a particular expertise in adjuvant therapy for Hormone-Receptor Positive breast cancer, metastatic breast cancer, and male breast cancer. His research background is in studying endocrine therapy action and resistance mechanisms, as well as targeted therapy to overcome it. His outpatient practice is exclusively dedicated to patients with breast cancer and his philosophy is centered around providing his patients with compassionate expert care. Cancer education and promoting clinical practice innovation is an integral part of his academic and leadership mission.
Dr. Massarweh has special expertise treating men with breast cancer, which is a rare disease with much research to be done. Incidence of breast cancer in men has been rising, however, and dedication to provide care and research is critical to advance this field and taylor care.
Dr. Massarweh is dedicated to healthcare transformation and using novel approaches to enhance integration of clinical care, research, and education that is driven by patient centered design. He is committed to improving care delivery processes and optimizing coordination of cancer care, with an emphasis on reducing patient wait times in the healthcare system. One example of care optimization processes developed by Dr. Massarweh at Stanford include One Less STOP (OLS) which delivers injectable breast cancer treatments in the clinic exam room instead of the chemotherapy suite with significant improvement in patient wait times and satisfaction through this patient centered design.
Dr. Massarweh's breast clinic team is highly trained to deliver cancer care excellence with a focus on optimizing patient care experiences in the healthcare system.
EXPERTISE AND RESEARCH INTERESTS
Adjuvant therapy for ER-positive breast cancer
Endocrine Resistance
Breast Cancer in Men
Triple Positive Breast Cancer
Clinical Trial Design
CLINICAL INTERESTS:
Metastatic Breast Cancer
Hormone Receptor Positive Breast Cancer
Breast Cancer in Men
Breast Cancer in Pregnant Women
Preoperative Endocrine Therapy
Clinical Practice Innovation
Administrative Appointments
-
Medical Director, Breast Clinical Care Program Leader, Stanford Cancer Center (2017 - 2018)
-
Director, Medical Oncology Fellowship Program, Stanford Medicine (2015 - 2018)
-
Leader, Breast Cancer Clinical Research Group (CRG), Stanford Cancer Institute (2015 - 2018)
-
Director, Breast Oncology Clinical Trials, Stanford Cancer Institute (2015 - Present)
-
Member, Translational Oncology Program, Stanford Cancer Institute (2015 - Present)
Honors & Awards
-
Likelihood to Recommend (LTR) Above 90th Percentile, National Ranking (2018)
-
Stanford GSB LEAD Certificate in Corporate Innovation, Stanford Graduate School of Business (2018)
-
The Saul A. Rosenberg Faculty Teaching Award, Stanford University School of Medicine (2017)
-
ASCO Leadership Skills Seminar, ASCO (2013)
-
AACR/ASCO Clinical Trials Workshop, ASCO/AACR (2004)
-
Merit Award, ASCO (2003)
-
Merit Award, ASCO Molecular Therapeutics Symposium (2002)
-
Merit Award, ASCO (2002)
Boards, Advisory Committees, Professional Organizations
-
Member, American Society of Clinical Oncology (2000 - Present)
-
Member, American Association of Cancer research (2002 - Present)
Professional Education
-
MD, University of Jordan faculty of Medicine, Medicine (1994)
-
Residency, Baylor College of Medicine, Internal Medicine (1999)
-
Fellowship, Baylor College of Medicine, Hematology-Oncology (2002)